Recent Advances and Perspectives of Metabolomics-Based Investigations in Coronary Heart Disease

Authors:

Abstract
Purpose of Review Coronary heart disease (CHD) is a major global threat to human health. This review summarizes the latest progress of metabolomics in CHD research, and provides insights into the pathogenesis and identify dependable biomarkers of CHD. Recent Findings This review has summarized 303 metabolic indicators related to CHD, with a focus on 53 biomarkers, and highlighted the top 10 biomarkers with significant clinical value. The biosynthesis of unsaturated fatty acids, amino acids, and aminoacyl-tRNA, as well as amino acid metabolism, are linked to CHD pathogenesis. Summary Amino acids and lipids play essential roles in understanding the onset and progression of CHD. This review provides a new perspective on enhancing our understanding of CHD pathogenesis and developing effective treatment interventions. Graphical Abstract
Funding Information
  • National Natural Science Foundation of China,China (No.81760708)
  • Jiangxi Provincial Academic and Technology Project for Main Disciplines Leader (No.20162BCB22016)

This publication has 95 references indexed in Scilit: